Global Bioresorbable Ophthalmic Drug Delivery System Market Growth 2025-2031

Publication ID:

LPI04258757

Publication Date:

April 15, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Bioresorbable Ophthalmic Drug Delivery System market size is predicted to grow from US$ 357 million in 2025 to US$ 531 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.
Bioresorbable implants are inserted into the patient鈥檚 eye and safely absorbed by the body over time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
publisher, Inc. (LPI) ' newest research report, the 鈥淏ioresorbable Ophthalmic Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Bioresorbable Ophthalmic Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioresorbable Ophthalmic Drug Delivery System sales for 2025 through 2031. With Bioresorbable Ophthalmic Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Ophthalmic Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Bioresorbable Ophthalmic Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioresorbable Ophthalmic Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bioresorbable Ophthalmic Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Ophthalmic Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Ophthalmic Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Ophthalmic Drug Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Anterior Drug Delivery Methods
Posterior Drug Delivery Methods
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Allergan
Re-Vana Therapeutics
PolyActiva
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bioresorbable Ophthalmic Drug Delivery System market?
What factors are driving Bioresorbable Ophthalmic Drug Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioresorbable Ophthalmic Drug Delivery System market opportunities vary by end market size?
How does Bioresorbable Ophthalmic Drug Delivery System break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bioresorbable Ophthalmic Drug Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bioresorbable Ophthalmic Drug Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Bioresorbable Ophthalmic Drug Delivery System Segment by Type
2.2.1 Anterior Drug Delivery Methods
2.2.2 Posterior Drug Delivery Methods
2.3 Bioresorbable Ophthalmic Drug Delivery System Sales by Type
2.3.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bioresorbable Ophthalmic Drug Delivery System Sale Price by Type (2020-2025)
2.4 Bioresorbable Ophthalmic Drug Delivery System Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Bioresorbable Ophthalmic Drug Delivery System Sales by Application
2.5.1 Global Bioresorbable Ophthalmic Drug Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bioresorbable Ophthalmic Drug Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bioresorbable Ophthalmic Drug Delivery System Breakdown Data by Company
3.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Bioresorbable Ophthalmic Drug Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Company (2020-2025)
3.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Bioresorbable Ophthalmic Drug Delivery System Sale Price by Company
3.4 Key Manufacturers Bioresorbable Ophthalmic Drug Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bioresorbable Ophthalmic Drug Delivery System Product Location Distribution
3.4.2 Players Bioresorbable Ophthalmic Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bioresorbable Ophthalmic Drug Delivery System by Geographic Region
4.1 World Historic Bioresorbable Ophthalmic Drug Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bioresorbable Ophthalmic Drug Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Bioresorbable Ophthalmic Drug Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bioresorbable Ophthalmic Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bioresorbable Ophthalmic Drug Delivery System Sales Growth
4.4 APAC Bioresorbable Ophthalmic Drug Delivery System Sales Growth
4.5 Europe Bioresorbable Ophthalmic Drug Delivery System Sales Growth
4.6 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Sales Growth
5 Americas
5.1 Americas Bioresorbable Ophthalmic Drug Delivery System Sales by Country
5.1.1 Americas Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2025)
5.1.2 Americas Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2025)
5.2 Americas Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2020-2025)
5.3 Americas Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioresorbable Ophthalmic Drug Delivery System Sales by Region
6.1.1 APAC Bioresorbable Ophthalmic Drug Delivery System Sales by Region (2020-2025)
6.1.2 APAC Bioresorbable Ophthalmic Drug Delivery System Revenue by Region (2020-2025)
6.2 APAC Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2020-2025)
6.3 APAC Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bioresorbable Ophthalmic Drug Delivery System by Country
7.1.1 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2025)
7.1.2 Europe Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2025)
7.2 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2020-2025)
7.3 Europe Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System by Country
8.1.1 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioresorbable Ophthalmic Drug Delivery System
10.3 Manufacturing Process Analysis of Bioresorbable Ophthalmic Drug Delivery System
10.4 Industry Chain Structure of Bioresorbable Ophthalmic Drug Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bioresorbable Ophthalmic Drug Delivery System Distributors
11.3 Bioresorbable Ophthalmic Drug Delivery System Customer
12 World Forecast Review for Bioresorbable Ophthalmic Drug Delivery System by Geographic Region
12.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Size Forecast by Region
12.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Forecast by Region (2026-2031)
12.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bioresorbable Ophthalmic Drug Delivery System Forecast by Type (2026-2031)
12.7 Global Bioresorbable Ophthalmic Drug Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Allergan
13.2.1 Allergan Company Information
13.2.2 Allergan Bioresorbable Ophthalmic Drug Delivery System Product Portfolios and Specifications
13.2.3 Allergan Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Allergan Main Business Overview
13.2.5 Allergan Latest Developments
13.3 Re-Vana Therapeutics
13.3.1 Re-Vana Therapeutics Company Information
13.3.2 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Product Portfolios and Specifications
13.3.3 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Re-Vana Therapeutics Main Business Overview
13.3.5 Re-Vana Therapeutics Latest Developments
13.4 PolyActiva
13.4.1 PolyActiva Company Information
13.4.2 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Product Portfolios and Specifications
13.4.3 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 PolyActiva Main Business Overview
13.4.5 PolyActiva Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂